United States Pharmaceuticals

Neurocrine Biosciences, Inc. (NBIX)

Track

Track

Neurocrine Biosciences experienced nineteen insider trading transactions over the past ninety days, all involving sales totaling approximately 16 million dollars. These divestments occurred following a positive earnings report in July. Key executives, including the Chief Legal and Regulatory Officers, executed these planned disposals, reflecting consistent liquidation activity despite stable stock performance during this period.
Ticker: NBIX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Neurocrine Biosciences, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ABERNETHY MATT Chief Financial Officer Officer
Transaction date
Planned sale
Price
233.78
Quantity 63,752 -46.2%
Value US$3,696,873
Boyer David W. Chief Corp. Affairs Officer Officer
Transaction date
Planned sale
Price
24.74
Quantity 96,506 +32.0%
Value US$3,855,356
MATTHEW C ABERNETHY Officer Officer
Transaction date
Proposed sale
Price
462.17
Quantity 20,569
Value US$2,279,238
DAVID WARREN BOYER Officer Officer
Transaction date
Proposed sale
Price
156.22
Quantity 1,000
Value US$100,000
BENEVICH ERIC Chief Commercial Officer Officer
Transaction date
Planned sale
Price
154.61
Quantity 1,000 -3.2%
Value US$100,000
BENEVICH ERIC Chief Commercial Officer Officer
Transaction date
Planned sale
Price
154.61
Quantity 1,000 -3.2%
Value US$100,000
ERIC BENEVICH Officer Officer
Transaction date
Proposed sale
Price
155.13
Quantity 1,000
Value US$100,000
Norwalk Leslie V Non-Executive Director
Transaction date
Planned sale
Price
182.01
Quantity 1,250 -44.0%
Value US$227,508
Delaet Ingrid Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
181.02
Quantity 4,367 -21.2%
Value US$790,514
INGRID DELAET Officer Officer
Transaction date
Proposed sale
Price
180.55
Quantity 4,367
Value US$788,462
Lippoldt Darin Chief Legal Officer Officer
Transaction date
Planned sale
Price
179.60
Quantity 10,000 -15.4%
Value US$1,796,014
Delaet Ingrid Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
178.72
Quantity 8,433 -34.2%
Value US$1,507,135
DARIN LIPPOLDT Officer Officer
Transaction date
Proposed sale
Price
178.24
Quantity 10,000
Value US$1,782,400
Delaet Ingrid Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
178.54
Quantity 2,737 -14.4%
Value US$488,672
Delaet Ingrid Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
178.57
Quantity 3,401 -17.3%
Value US$607,305
INGRID DELAET Officer Officer
Transaction date
Proposed sale
Price
174.10
Quantity 14,571
Value US$2,536,811
Lippoldt Darin Chief Legal Officer Officer
Transaction date
Planned sale
Price
170.81
Quantity 1,690 -3.0%
Value US$288,676
Lippoldt Darin Chief Legal Officer Officer
Transaction date
Planned sale
Price
170.03
Quantity 8,110 -12.9%
Value US$1,378,903
DARIN LIPPOLDT Officer Officer
Transaction date
Proposed sale
Price
168.52
Quantity 9,800
Value US$1,651,496
Lippoldt Darin Chief Legal Officer Officer
Transaction date
Planned sale
Price
169.57
Quantity 200 -0.4%
Value US$33,913
DARIN LIPPOLDT Officer Officer
Transaction date
Proposed sale
Price
164.18
Quantity 200
Value US$32,836
3.1
SHERWIN STEPHEN A Non-Executive Director
Transaction date
Planned sale
Price
167.31
Quantity 1,843 -10.4%
Value US$308,357
3.1
SHERWIN STEPHEN A Non-Executive Director
Transaction date
Planned sale
Price
166.56
Quantity 5,829 -24.8%
Value US$970,859
3.1
SHERWIN STEPHEN A Non-Executive Director
Transaction date
Planned sale
Price
165.79
Quantity 6,896 -22.7%
Value US$1,143,306
3.1
SHERWIN STEPHEN A Non-Executive Director
Transaction date
Planned sale
Price
164.44
Quantity 2,549 -7.7%
Value US$419,156
3.1
SHERWIN STEPHEN A Non-Executive Director
Transaction date
Planned sale
Price
163.81
Quantity 7,883 -19.3%
Value US$1,291,291
3.1
STEPHEN SHERWIN Director Non-Executive Director
Transaction date
Proposed sale
Price
167.35
Quantity 25,000
Value US$4,183,750
3.1
STEPHEN SHERWIN Director Non-Executive Director
Transaction date
Proposed sale
Price
167.35
Quantity 25,000
Value US$4,183,750
Norwalk Leslie V Non-Executive Director
Transaction date
Planned sale
Price
168.06
Quantity 1,250 -30.6%
Value US$210,072
Cooke Julie Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
158.59
Quantity 3,520 -13.6%
Value US$558,236
Cooke Julie Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
157.62
Quantity 9,521 -26.9%
Value US$1,500,663
Cooke Julie Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
156.77
Quantity 4,216 -10.6%
Value US$660,925
Cooke Julie Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
155.46
Quantity 5,466 -12.1%
Value US$849,726
Cooke Julie Chief Human Resources Officer Officer
Transaction date
Planned sale
Price
154.83
Quantity 14,214 -24.0%
Value US$2,200,685
JULIE COOKE Officer Officer
Transaction date
Proposed sale
Price
161.00
Quantity 36,937
Value US$5,946,857
3.4
Onyia Jude Chief Scientific Officer Officer
Transaction date
Planned sale
Price
160.25
Quantity 11,000 -29.9%
Value US$1,762,710
3.4
JUDE ONYIA Officer Officer
Transaction date
Proposed sale
Price
158.30
Quantity 11,000
Value US$1,741,300
Delaet Ingrid Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
156.71
Quantity 2,261 -12.2%
Value US$354,321
INGRID DELAET Officer Officer
Transaction date
Proposed sale
Price
156.39
Quantity 2,261
Value US$353,598
3.4
Onyia Jude Chief Scientific Officer Officer
Transaction date
Planned sale
Price
155.53
Quantity 11,000 -29.9%
Value US$1,710,865
3.4
JUDE ONYIA Officer Officer
Transaction date
Proposed sale
Price
155.73
Quantity 11,000
Value US$1,713,030
Boyer David W. Chief Corp. Affairs Officer Officer
Transaction date
Planned sale
Price
156.64
Quantity 3,888 -33.3%
Value US$609,023
DAVID WARREN BOYER Officer Officer
Transaction date
Proposed sale
Price
156.70
Quantity 3,888
Value US$609,250
3.1
GORMAN KEVIN CHARLES Non-Executive Director
Transaction date
Planned sale
Price
154.33
Quantity 245,088 -32.4%
Value US$37,824,872
3.1
KEVIN CHARLES GORMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
157.21
Quantity 245,088
Value US$38,530,284
2.7
POPS RICHARD F Non-Executive Director
Transaction date
Planned sale
Price
157.65
Quantity 15,000 -30.3%
Value US$2,364,760
2.7
RICHARD F POPS Director Non-Executive Director
Transaction date
Proposed sale
Price
159.05
Quantity 15,000
Value US$2,385,750
2.7
RICHARD F POPS Director Non-Executive Director
Transaction date
Proposed sale
Price
159.05
Quantity 15,000
Value US$2,385,750
Norwalk Leslie V Non-Executive Director
Transaction date
Planned sale
Price
155.01
Quantity 3,810 -61.1%
Value US$590,601
Norwalk Leslie V Director Non-Executive Director
Transaction date
Proposed sale
Price
162.92
Quantity 6,310
Value US$1,028,050
Gano Kyle Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
132.71
Quantity 1,812 -1.3%
Value US$240,478
Gano Kyle Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
132.70
Quantity 34,588 -19.8%
Value US$4,589,980
KYLE GANO Officer Officer
Transaction date
Proposed sale
Price
133.35
Quantity 36,400
Value US$4,853,940
Norwalk Leslie V Non-Executive Director
Transaction date
Planned sale
Price
155.09
Quantity 1,190 -16.0%
Value US$184,558
Norwalk Leslie V Non-Executive Director
Transaction date
Planned sale
Price
152.23
Quantity 5,000 -40.2%
Value US$761,144
Norwalk Leslie V Director Non-Executive Director
Transaction date
Proposed sale
Price
155.11
Quantity 11,250
Value US$1,745,000
Lippoldt Darin Chief Legal Officer Officer
Transaction date
Planned sale
Price
159.65
Quantity 4,376 -9.2%
Value US$698,615
DARIN LIPPOLDT Officer Officer
Transaction date
Proposed sale
Price
155.51
Quantity 4,376
Value US$680,512
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
152.61
Quantity 15,000 -11.1%
Value US$2,289,082
BENEVICH ERIC Chief Commercial Officer Officer
Transaction date
Planned sale
Price
151.74
Quantity 5,970 -11.7%
Value US$905,881
ERIC BENEVICH Officer Officer
Transaction date
Proposed sale
Price
151.58
Quantity 5,970
Value US$904,933
2.8
MORROW GEORGE J Non-Executive Director
Transaction date
Planned sale
Price
143.37
Quantity 15,000 -68.0%
Value US$2,150,512
2.8
GEORGE MORROW Director Non-Executive Director
Transaction date
Proposed sale
Price
141.25
Quantity 15,000
Value US$2,118,750
3.0
RASTETTER WILLIAM H Non-Executive Director
Transaction date
Planned sale
Price
151.82
Quantity 18,000 -30.8%
Value US$2,732,690
3.0
WILLIAM H. RASTETTER Director Non-Executive Director
Transaction date
Proposed sale
Price
143.19
Quantity 18,000
Value US$2,577,420
Gano Kyle Officer; Director Executive Director
Transaction date
Proposed sale
Price
141.97
Quantity 300
Value US$42,591
Gano Kyle Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
141.97
Quantity 300 -0.2%
Value US$42,591
3.1
GORMAN KEVIN CHARLES Non-Executive Director
Transaction date
Planned sale
Price
126.41
Quantity 106,322 -17.1%
Value US$13,440,281
3.1
KEVIN CHARLES GORMAN Director Non-Executive Director
Transaction date
Proposed sale
Price
128.43
Quantity 106,322
Value US$13,654,934
Delaet Ingrid Chief Regulatory Officer Officer
Transaction date
Planned sale
Price
135.00
Quantity 457 -8.8%
Value US$61,695
INGRID DELAET Officer Officer
Transaction date
Proposed sale
Price
133.51
Quantity 457
Value US$61,014
3.4
Onyia Jude Chief Scientific Officer Officer
Transaction date
Planned sale
Price
130.46
Quantity 59,819 -76.6%
Value US$7,803,688
3.4
Onyia Jude Chief Scientific Officer Officer
Transaction date
Planned sale
Price
130.13
Quantity 20,362 -52.7%
Value US$2,649,738
3.4
JUDE ONYIA Officer Officer
Transaction date
Proposed sale
Price
128.00
Quantity 80,181
Value US$10,263,168
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-15 2026-09-14 PlS Planned sale
ABERNETHY MATT

Chief Financial Officer

Officer
63,752 -46.2%
233.78
US$3,696,873 		63,752 -46.2% 233.78 US$3,696,873
2026-09-15 2026-09-14 PlS Planned sale
Boyer David W.

Chief Corp. Affairs Officer

Officer
96,506 +32.0%
24.74
US$3,855,356 		96,506 +32.0% 24.74 US$3,855,356
2026-09-14 2026-09-14 PrS Proposed sale
MATTHEW C ABERNETHY

Officer

Officer
20,569
462.17
US$2,279,238 		20,569 462.17 US$2,279,238
2026-09-14 2026-09-14 PrS Proposed sale
DAVID WARREN BOYER

Officer

Officer
1,000
156.22
US$100,000 		1,000 156.22 US$100,000
2026-09-10 2026-09-09 PlS Planned sale
BENEVICH ERIC

Chief Commercial Officer

Officer
1,000 -3.2%
154.61
US$100,000 		1,000 -3.2% 154.61 US$100,000
2026-09-10 2026-09-09 PlS Planned sale
BENEVICH ERIC

Chief Commercial Officer

Officer
1,000 -3.2%
154.61
US$100,000 		1,000 -3.2% 154.61 US$100,000
2026-09-09 2026-09-09 PrS Proposed sale
ERIC BENEVICH

Officer

Officer
1,000
155.13
US$100,000 		1,000 155.13 US$100,000
2026-07-30 2026-07-28 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
1,250 -44.0%
182.01
US$227,508 		1,250 -44.0% 182.01 US$227,508
2026-07-13 2026-07-10 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
4,367 -21.2%
181.02
US$790,514 		4,367 -21.2% 181.02 US$790,514
2026-07-10 2026-07-10 PrS Proposed sale
INGRID DELAET

Officer

Officer
4,367
180.55
US$788,462 		4,367 180.55 US$788,462
2026-07-13 2026-07-09 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
10,000 -15.4%
179.60
US$1,796,014 		10,000 -15.4% 179.60 US$1,796,014
2026-07-09 2026-07-09 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
8,433 -34.2%
178.72
US$1,507,135 		8,433 -34.2% 178.72 US$1,507,135
2026-07-09 2026-07-09 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
10,000
178.24
US$1,782,400 		10,000 178.24 US$1,782,400
2026-07-09 2026-07-08 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
2,737 -14.4%
178.54
US$488,672 		2,737 -14.4% 178.54 US$488,672
2026-07-09 2026-07-07 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
3,401 -17.3%
178.57
US$607,305 		3,401 -17.3% 178.57 US$607,305
2026-07-07 2026-07-07 PrS Proposed sale
INGRID DELAET

Officer

Officer
14,571
174.10
US$2,536,811 		14,571 174.10 US$2,536,811
2026-06-30 2026-06-29 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
1,690 -3.0%
170.81
US$288,676 		1,690 -3.0% 170.81 US$288,676
2026-06-30 2026-06-29 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
8,110 -12.9%
170.03
US$1,378,903 		8,110 -12.9% 170.03 US$1,378,903
2026-06-29 2026-06-29 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
9,800
168.52
US$1,651,496 		9,800 168.52 US$1,651,496
2026-06-30 2026-06-26 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
200 -0.4%
169.57
US$33,913 		200 -0.4% 169.57 US$33,913
2026-06-26 2026-06-26 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
200
164.18
US$32,836 		200 164.18 US$32,836
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
1,843 -10.4%
167.31
US$308,357 		1,843 -10.4% 167.31 US$308,357
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
5,829 -24.8%
166.56
US$970,859 		5,829 -24.8% 166.56 US$970,859
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
6,896 -22.7%
165.79
US$1,143,306 		6,896 -22.7% 165.79 US$1,143,306
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
2,549 -7.7%
164.44
US$419,156 		2,549 -7.7% 164.44 US$419,156
2026-06-09 2026-06-05 PlS Planned sale
3.1
SHERWIN STEPHEN A
Non-Executive Director
7,883 -19.3%
163.81
US$1,291,291 		7,883 -19.3% 163.81 US$1,291,291
2026-06-05 2026-06-05 PrS Proposed sale
3.1
STEPHEN SHERWIN

Director

Non-Executive Director
25,000
167.35
US$4,183,750 		25,000 167.35 US$4,183,750
2026-06-05 2026-06-05 PrS Proposed sale
3.1
STEPHEN SHERWIN

Director

Non-Executive Director
25,000
167.35
US$4,183,750 		25,000 167.35 US$4,183,750
2026-06-08 2026-06-04 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
1,250 -30.6%
168.06
US$210,072 		1,250 -30.6% 168.06 US$210,072
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
3,520 -13.6%
158.59
US$558,236 		3,520 -13.6% 158.59 US$558,236
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
9,521 -26.9%
157.62
US$1,500,663 		9,521 -26.9% 157.62 US$1,500,663
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
4,216 -10.6%
156.77
US$660,925 		4,216 -10.6% 156.77 US$660,925
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
5,466 -12.1%
155.46
US$849,726 		5,466 -12.1% 155.46 US$849,726
2026-06-04 2026-06-02 PlS Planned sale
Cooke Julie

Chief Human Resources Officer

Officer
14,214 -24.0%
154.83
US$2,200,685 		14,214 -24.0% 154.83 US$2,200,685
2026-06-02 2026-06-02 PrS Proposed sale
JULIE COOKE

Officer

Officer
36,937
161.00
US$5,946,857 		36,937 161.00 US$5,946,857
2026-06-02 2026-06-01 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
11,000 -29.9%
160.25
US$1,762,710 		11,000 -29.9% 160.25 US$1,762,710
2026-06-01 2026-06-01 PrS Proposed sale
3.4
JUDE ONYIA

Officer

Officer
11,000
158.30
US$1,741,300 		11,000 158.30 US$1,741,300
2026-06-02 2026-05-29 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
2,261 -12.2%
156.71
US$354,321 		2,261 -12.2% 156.71 US$354,321
2026-05-29 2026-05-29 PrS Proposed sale
INGRID DELAET

Officer

Officer
2,261
156.39
US$353,598 		2,261 156.39 US$353,598
2026-05-29 2026-05-27 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
11,000 -29.9%
155.53
US$1,710,865 		11,000 -29.9% 155.53 US$1,710,865
2026-05-27 2026-05-27 PrS Proposed sale
3.4
JUDE ONYIA

Officer

Officer
11,000
155.73
US$1,713,030 		11,000 155.73 US$1,713,030
2026-05-28 2026-05-26 PlS Planned sale
Boyer David W.

Chief Corp. Affairs Officer

Officer
3,888 -33.3%
156.64
US$609,023 		3,888 -33.3% 156.64 US$609,023
2026-05-26 2026-05-26 PrS Proposed sale
DAVID WARREN BOYER

Officer

Officer
3,888
156.70
US$609,250 		3,888 156.70 US$609,250
2026-05-21 2026-05-19 PlS Planned sale
3.1
GORMAN KEVIN CHARLES
Non-Executive Director
245,088 -32.4%
154.33
US$37,824,872 		245,088 -32.4% 154.33 US$37,824,872
2026-05-19 2026-05-19 PrS Proposed sale
3.1
KEVIN CHARLES GORMAN

Director

Non-Executive Director
245,088
157.21
US$38,530,284 		245,088 157.21 US$38,530,284
2026-05-18 2026-05-15 PlS Planned sale
2.7
POPS RICHARD F
Non-Executive Director
15,000 -30.3%
157.65
US$2,364,760 		15,000 -30.3% 157.65 US$2,364,760
2026-05-15 2026-05-15 PrS Proposed sale
2.7
RICHARD F POPS

Director

Non-Executive Director
15,000
159.05
US$2,385,750 		15,000 159.05 US$2,385,750
2026-05-15 2026-05-15 PrS Proposed sale
2.7
RICHARD F POPS

Director

Non-Executive Director
15,000
159.05
US$2,385,750 		15,000 159.05 US$2,385,750
2026-05-14 2026-05-12 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
3,810 -61.1%
155.01
US$590,601 		3,810 -61.1% 155.01 US$590,601
2026-05-12 2026-05-12 PrS Proposed sale
Norwalk Leslie V

Director

Non-Executive Director
6,310
162.92
US$1,028,050 		6,310 162.92 US$1,028,050
2026-01-20 2026-01-16 PlS Planned sale
Gano Kyle

Chief Executive Officer

Executive Director
1,812 -1.3%
132.71
US$240,478 		1,812 -1.3% 132.71 US$240,478
2026-01-20 2026-01-16 PlS Planned sale
Gano Kyle

Chief Executive Officer

Executive Director
34,588 -19.8%
132.70
US$4,589,980 		34,588 -19.8% 132.70 US$4,589,980
2026-01-16 2026-01-16 PrS Proposed sale
KYLE GANO

Officer

Officer
36,400
133.35
US$4,853,940 		36,400 133.35 US$4,853,940
2025-12-17 2025-12-16 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
1,190 -16.0%
155.09
US$184,558 		1,190 -16.0% 155.09 US$184,558
2025-12-17 2025-12-15 PlS Planned sale
Norwalk Leslie V
Non-Executive Director
5,000 -40.2%
152.23
US$761,144 		5,000 -40.2% 152.23 US$761,144
2025-12-15 2025-12-15 PrS Proposed sale
Norwalk Leslie V

Director

Non-Executive Director
11,250
155.11
US$1,745,000 		11,250 155.11 US$1,745,000
2025-12-10 2025-12-08 PlS Planned sale
Lippoldt Darin

Chief Legal Officer

Officer
4,376 -9.2%
159.65
US$698,615 		4,376 -9.2% 159.65 US$698,615
2025-12-08 2025-12-08 PrS Proposed sale
DARIN LIPPOLDT

Officer

Officer
4,376
155.51
US$680,512 		4,376 155.51 US$680,512
2025-12-04 2025-12-03 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
15,000 -11.1%
152.61
US$2,289,082 		15,000 -11.1% 152.61 US$2,289,082
2025-12-03 2025-12-03 PrS Proposed sale
2.2
GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012

Director

Non-Executive Director
15,000
152.48
US$2,287,200 		15,000 152.48 US$2,287,200
2025-12-02 2025-11-28 PlS Planned sale
BENEVICH ERIC

Chief Commercial Officer

Officer
5,970 -11.7%
151.74
US$905,881 		5,970 -11.7% 151.74 US$905,881
2025-11-28 2025-11-28 PrS Proposed sale
ERIC BENEVICH

Officer

Officer
5,970
151.58
US$904,933 		5,970 151.58 US$904,933
2025-11-26 2025-11-25 PlS Planned sale
2.8
MORROW GEORGE J
Non-Executive Director
15,000 -68.0%
143.37
US$2,150,512 		15,000 -68.0% 143.37 US$2,150,512
2025-11-25 2025-11-25 PrS Proposed sale
2.8
GEORGE MORROW

Director

Non-Executive Director
15,000
141.25
US$2,118,750 		15,000 141.25 US$2,118,750
2025-11-06 2025-11-05 PlS Planned sale
3.0
RASTETTER WILLIAM H
Non-Executive Director
18,000 -30.8%
151.82
US$2,732,690 		18,000 -30.8% 151.82 US$2,732,690
2025-11-05 2025-11-05 PrS Proposed sale
3.0
WILLIAM H. RASTETTER

Director

Non-Executive Director
18,000
143.19
US$2,577,420 		18,000 143.19 US$2,577,420
2025-11-05 2025-11-04 PrS Proposed sale
Gano Kyle

Officer; Director

Executive Director
300
141.97
US$42,591 		300 141.97 US$42,591
2025-11-04 2025-11-04 PlS Planned sale
Gano Kyle

Chief Executive Officer

Executive Director
300 -0.2%
141.97
US$42,591 		300 -0.2% 141.97 US$42,591
2025-08-11 2025-08-07 PlS Planned sale
3.1
GORMAN KEVIN CHARLES
Non-Executive Director
106,322 -17.1%
126.41
US$13,440,281 		106,322 -17.1% 126.41 US$13,440,281
2025-08-07 2025-08-07 PrS Proposed sale
3.1
KEVIN CHARLES GORMAN

Director

Non-Executive Director
106,322
128.43
US$13,654,934 		106,322 128.43 US$13,654,934
2025-07-11 2025-07-10 PlS Planned sale
Delaet Ingrid

Chief Regulatory Officer

Officer
457 -8.8%
135.00
US$61,695 		457 -8.8% 135.00 US$61,695
2025-07-10 2025-07-10 PrS Proposed sale
INGRID DELAET

Officer

Officer
457
133.51
US$61,014 		457 133.51 US$61,014
2025-07-11 2025-07-09 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
59,819 -76.6%
130.46
US$7,803,688 		59,819 -76.6% 130.46 US$7,803,688
2025-07-07 2025-07-02 PlS Planned sale
3.4
Onyia Jude

Chief Scientific Officer

Officer
20,362 -52.7%
130.13
US$2,649,738 		20,362 -52.7% 130.13 US$2,649,738
2025-07-02 2025-07-02 PrS Proposed sale
3.4
JUDE ONYIA

Officer

Officer
80,181
128.00
US$10,263,168 		80,181 128.00 US$10,263,168
Explore more

More insider trading research around Neurocrine Biosciences, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America